Related Articles
VEGF‑C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin
Cisplatin resistance by induction of aldo‑keto reductase family 1 member C2 in human bladder cancer cells
Effect of the PARP inhibitor veliparib on germ cell tumor cell lines
Maspin protein expression correlates with tumor progression in non-muscle invasive bladder cancer
Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells